These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

76 related articles for article (PubMed ID: 19373312)

  • 1. [Limitations of data for NORRISK].
    Selmer R; Lindman AS; Tverdal A; Pedersen JI; Veierød MB; Njølstad I
    Tidsskr Nor Laegeforen; 2009 Apr; 129(8):771. PubMed ID: 19373312
    [No Abstract]   [Full Text] [Related]  

  • 2. [Model for estimation of cardiovascular risk in Norway].
    Selmer R; Lindman AS; Tverdal A; Pedersen JI; Njølstad I; Veierød MB
    Tidsskr Nor Laegeforen; 2008 Jan; 128(3):286-90. PubMed ID: 18264151
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Coronary artery calcification predicts long-term mortality in hypertensive adults.
    Shemesh J; Motro M; Morag-Koren N; Tenenbaum A; Apter S; Weiss A; Grossman E
    Am J Hypertens; 2011 Jun; 24(6):681-6. PubMed ID: 21372801
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Assessing cardiac risk in the renal patient: do the general rules apply?
    Soman P; Jain D
    Nucl Med Commun; 2008 Jun; 29(6):507-10. PubMed ID: 18458596
    [No Abstract]   [Full Text] [Related]  

  • 5. Progression rate of ALSFRS-R at time of diagnosis predicts survival time in ALS.
    Gordon PH; Cheung YK
    Neurology; 2006 Oct; 67(7):1314-5; author reply 1314-5. PubMed ID: 17030785
    [No Abstract]   [Full Text] [Related]  

  • 6. Quantitative T-wave alternans: could an index adjusting for T-wave amplitude be even better?
    Madias JE
    J Cardiovasc Electrophysiol; 2009 Jun; 20(6):E65; author reply E64. PubMed ID: 19470034
    [No Abstract]   [Full Text] [Related]  

  • 7. Plasma levels of soluble receptor for advanced glycation end products are associated with endothelial function and predict cardiovascular events in nondiabetic patients.
    Chiang KH; Huang PH; Huang SS; Wu TC; Chen JW; Lin SJ
    Coron Artery Dis; 2009 Jun; 20(4):267-73. PubMed ID: 19440065
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Multivessel disease in diabetics: does DES level the field?
    Hillegass W
    Catheter Cardiovasc Interv; 2009 Jun; 73(7):881-2. PubMed ID: 19455651
    [No Abstract]   [Full Text] [Related]  

  • 9. Multilevel survival modelling of recurrent urinary tract infections.
    Wang K; Yau KK; Lee AH; McLachlan GJ
    Comput Methods Programs Biomed; 2007 Sep; 87(3):225-9. PubMed ID: 17619063
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Preprocedural high-sensitivity C-reactive protein predicts death or myocardial infarction but not target vessel revascularization or stent thrombosis after percutaneous coronary intervention.
    Delhaye C; Sudre A; Lemesle G; Maréchaux S; Broucqsault D; Hennache B; Bauters C; Lablanche JM
    Cardiovasc Revasc Med; 2009; 10(3):144-50. PubMed ID: 19595394
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Atrial fibrillation significantly increases total mortality and stroke risk beyond that conveyed by the CHADS2 risk factors.
    Crandall MA; Horne BD; Day JD; Anderson JL; Muhlestein JB; Crandall BG; Weiss JP; Osborne JS; Lappé DL; Bunch TJ
    Pacing Clin Electrophysiol; 2009 Aug; 32(8):981-6. PubMed ID: 19659615
    [TBL] [Abstract][Full Text] [Related]  

  • 12. From poverty to prosperity--a hazard to the health.
    Forsdahl A
    Arctic Med Res; 1988; 47 Suppl 1():60-2. PubMed ID: 3272697
    [No Abstract]   [Full Text] [Related]  

  • 13. [Integration of a new risk marker into cardiovascular prevention, using coronary calcium as an example].
    Möhlenkamp S; Lehmann N; Moebus S; Schmermund A; Jöckel KH; Erbel R;
    Dtsch Med Wochenschr; 2009 Oct; 134(40):2023-6. PubMed ID: 19777421
    [No Abstract]   [Full Text] [Related]  

  • 14. Is the aortic valve pathology type different for early and late mortality in concomitant aortic valve replacement and coronary artery bypass surgery?
    Gunay R; Sensoz Y; Kayacioglu I; Tuygun AK; Balci AY; Kisa U; Demirtas MM; Yekeler I
    Interact Cardiovasc Thorac Surg; 2009 Oct; 9(4):630-4. PubMed ID: 19625469
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Using the Restricted Mean Survival Time Difference as an Alternative to the Hazard Ratio for Analyzing Clinical Cardiovascular Studies.
    McCaw ZR; Yin G; Wei LJ
    Circulation; 2019 Oct; 140(17):1366-1368. PubMed ID: 31634007
    [No Abstract]   [Full Text] [Related]  

  • 16. Value and limitations of existing scores for the assessment of cardiovascular risk: a review for clinicians.
    Cooney MT; Dudina AL; Graham IM
    J Am Coll Cardiol; 2009 Sep; 54(14):1209-27. PubMed ID: 19778661
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The adverse prognostic significance of the metabolic syndrome with and without hypertension in patients who underwent complete coronary revascularization.
    Kasai T; Miyauchi K; Kajimoto K; Kubota N; Dohi T; Kurata T; Amano A; Daida H
    J Hypertens; 2009 May; 27(5):1017-24. PubMed ID: 19381109
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of metabolic syndrome on future cardiovascular events in patients with first acute myocardial infarction.
    Selcuk H; Temizhan A; Selcuk MT; Sen T; Maden O; Tekeli S; Sasmaz A
    Coron Artery Dis; 2009 Sep; 20(6):370-5. PubMed ID: 19609207
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cardiovascular risk reduction in high-risk pediatric populations.
    American Academy of Pediatrics
    Pediatrics; 2007 Mar; 119(3):618-21. PubMed ID: 17332217
    [No Abstract]   [Full Text] [Related]  

  • 20. Does fibrinogen add to prediction of cardiovascular disease? Results from the Scottish Heart Health Extended Cohort Study.
    Woodward M; Tunstall-Pedoe H; Rumley A; Lowe GD
    Br J Haematol; 2009 Aug; 146(4):442-6. PubMed ID: 19549268
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.